LAMEA Artificial Intelligence In Precision Medicine Market Size, Share & Industry Trends Analysis Report By Application (Oncology, Cardiology, Neurology, Respiratory), By Component (Software, Hardware and Service), By Technology, By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Artificial Intelligence In Precision Medicine Market would witness market growth of 35.4% CAGR during the forecast period (2022-2028).

Precision medicine has already produced significant new findings and FDA-approved therapies that are tailored to a person's unique traits, such as their genetic makeup or the genetic profile of their tumor. Molecular testing is frequently administered to patients with different types of cancer as part of patient care, allowing medical professionals to choose therapies that raise survival rates and lower the risk of side effects.

The market for precision medicine is developing due to the increasing R&D expenditures and increased demand for customized drugs. Collaboration amongst important businesses is further propelling the industry's growth. As an illustration, in August 2022, Sanofi and Atomwise reached an agreement for USD 20 million, and Sanofi planned to utilize Atomwise's AtomNet system for research and computational discovery study on up to five therapeutic targets.

The platform incorporates deep learning-based components for the structure-based designing of pharmaceuticals through quick, AI-powered searches of the company's exclusive library of more than three trillion synthesizable complexes.

Qatar has a pretty special chance to lead precision health due to its highly homogenous gene pool and prevalent in-group illnesses. Precision medicine will benefit greatly from the development of machine learning (ML), artificial intelligence (AI), deep learning (DL), and big data analytics. Additionally, wearable sensors and information and communication technology, in general, are fostering a higher degree of precision in healthcare. The implementation of personalized healthcare efforts in Qatar is a component of a coordinated and all-encompassing precision medicine approach.

The Brazil market dominated the LAMEA Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $99.7 Million by 2028.The Argentina market is experiencing a CAGR of 36.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 35% during (2022 - 2028).

Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Artificial Intelligence In Precision Medicine Market is Predict to reach $6.3 Billion by 2028, at a CAGR of 32.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Oncology
• Cardiology
• Neurology
• Respiratory
• Others

By Component

• Software
• Hardware
• Service

By Technology

• Deep Learning
• Natural Language Processing
• Querying Method
• Context Aware Processing

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• General Electric (GE) Co. (GE Healthcare)
• Sanofi S.A.
• NVIDIA Corporation
• Intel Corporation
• Microsoft Corporation
• IBM Corporation
• Google LLC (Alphabet Inc.)
• AstraZeneca PLC
• Tempus, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

Global Artificial Intelligence In Precision Medicine Market Report 2022-2028

North America Artificial Intelligence In Precision Medicine Market Report 2022-2028

Europe Artificial Intelligence In Precision Medicine Market Report 2022-2028

Asia Pacific Artificial Intelligence In Precision Medicine Market Report 2022-2028